XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 851,660 $ 21,952,000 $ 2,136 $ 36,843,326 $ (48,495,076) $ 11,154,046
Balance (in Shares) at Dec. 31, 2020 170,332 21,952 21,359,945      
Provision for compensation expense related to stock options 380,263 380,263
Issuance of warrants in connection with consulting agreement 212,923 212,923
Exercise of stock options into common stock $ 2 12,910 12,912
Exercise of stock options into common stock (in Shares)     16,000      
Net income (loss) 1,237 1,237
Balance at Mar. 31, 2021 $ 851,660 $ 21,952,000 $ 2,138 37,449,422 (48,493,839) 11,761,381
Balance (in Shares) at Mar. 31, 2021 170,332 21,952 21,375,945      
Balance at Dec. 31, 2020 $ 851,660 $ 21,952,000 $ 2,136 36,843,326 (48,495,076) 11,154,046
Balance (in Shares) at Dec. 31, 2020 170,332 21,952 21,359,945      
Net income (loss)           943,431
Balance at Jun. 30, 2021 $ 851,660 $ 21,952,000 $ 2,138 37,894,784 (47,551,645) 13,148,937
Balance (in Shares) at Jun. 30, 2021 170,332 21,952 21,381,278      
Balance at Mar. 31, 2021 $ 851,660 $ 21,952,000 $ 2,138 37,449,422 (48,493,839) 11,761,381
Balance (in Shares) at Mar. 31, 2021 170,332 21,952 21,375,945      
Provision for compensation expense related to stock options 249,222 249,222
Issuance of warrants in connection with consulting agreement 191,926 191,926
Exercise of stock options into common stock 4,214 4,214
Exercise of stock options into common stock (in Shares) 5,333      
Net income (loss) 942,194 942,194
Balance at Jun. 30, 2021 $ 851,660 $ 21,952,000 $ 2,138 37,894,784 (47,551,645) 13,148,937
Balance (in Shares) at Jun. 30, 2021 170,332 21,952 21,381,278      
Balance at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144 38,560,117 (45,222,302) 16,143,619
Balance (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278      
Provision for compensation expense related to stock options 305,229 305,229
Exercise of stock options into common stock $ 17 137,040 137,057
Exercise of stock options into common stock (in Shares)     162,956      
Net income (loss) (2,380,935) (2,380,935)
Balance at Mar. 31, 2022 $ 851,660 $ 21,952,000 $ 2,161 39,002,386 (47,603,237) 14,204,970
Balance (in Shares) at Mar. 31, 2022 170,332 21,952 21,605,234      
Balance at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144 38,560,117 (45,222,302) 16,143,619
Balance (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278      
Net income (loss)           12,008,286
Balance at Jun. 30, 2022 $ 851,660 $ 21,952,000 $ 2,161 39,259,862 (33,214,016) 28,851,667
Balance (in Shares) at Jun. 30, 2022 170,332 21,952 21,605,234      
Balance at Mar. 31, 2022 $ 851,660 $ 21,952,000 $ 2,161 39,002,386 (47,603,237) 14,204,970
Balance (in Shares) at Mar. 31, 2022 170,332 21,952 21,605,234      
Provision for compensation expense related to stock options 257,476 257,476
Net income (loss) 14,389,221 14,389,221
Balance at Jun. 30, 2022 $ 851,660 $ 21,952,000 $ 2,161 $ 39,259,862 $ (33,214,016) $ 28,851,667
Balance (in Shares) at Jun. 30, 2022 170,332 21,952 21,605,234